pathogen.vim VS GiveForms

• Ease of Use
  Pathogen.vim simplifies the management of Vim plugins by allowing users to easily install, update, and remove plugins without altering Vim's core files. It requires minimal configuration.
• Directory Structure
  It promotes a cleaner directory structure where each plugin resides in its own directory under .vim/bundle, making it easier to locate and manage individual plugins.
• Compatibility
  Being widely adopted and time-tested, pathogen.vim is compatible with a wide range of plugins. This ensures that users can confidently use popular Vim plugins alongside it.
• No Impact on Startup Time
  Pathogen.vim is lightweight, which means it doesn't significantly affect Vim's startup time, preserving Vim's reputation for speed and efficiency.

Possible disadvantages

• Limited Features
  Compared to modern plugin managers like vim-plug or Vundle, pathogen.vim offers limited features, lacking built-in update mechanisms for plugins or other advanced functionalities.
• Manual Management of Dependencies
  Pathogen.vim requires users to manually manage plugin dependencies and updates, which can become cumbersome when dealing with a large number of plugins.
• Exclusivity of Git for Installation
  Pathogen.vim relies heavily on Git for plugin installation, which might be a limitation for users who prefer or require alternative installation methods.

• Ease of Use
  GiveForms offers a user-friendly interface that makes it easy for nonprofits to set up and manage donation forms without needing extensive technical knowledge.
• Customization
  The platform provides various customization options to tailor the appearance and functionality of donation forms to meet specific organizational needs and branding guidelines.
• Mobile Responsiveness
  GiveForms ensures that all donation forms are mobile-responsive, allowing donors to contribute easily from any device, whether it's a smartphone, tablet, or desktop.
• Payment Processing
  Supports multiple payment methods, including credit/debit cards and digital wallets, which makes it flexible and convenient for donors.
• Analytics and Reporting
  Offers built-in analytics and reporting features to track donations and donor behavior, helping nonprofits make data-driven decisions.

Possible disadvantages

• Pricing
  While GiveForms offers a range of features, it might be considered pricey for smaller nonprofits or organizations with limited budgets.
• Limited Payment Gateways
  The platform may not support all payment gateways, which could be a limitation for organizations that have specific payment processing needs.
• Feature Gaps for Advanced Users
  May lack some advanced customization or integration features that more tech-savvy users or larger organizations might require.
• Dependence on Internet
  As a web-based platform, it requires a reliable internet connection to manage forms and process donations, which can be a constraint in areas with connectivity issues.
• Learning Curve for Detailed Customization
  While the basic setup is straightforward, there might be a learning curve for users who wish to take advantage of more detailed customization options.

No analysis of pathogen.vim yet.

• Any Suggestions Apart from vscode for Terraform ?

  The person who mentored me the most when I was getting started with Terraform used VIM with pathogen but honestly this isn't a great idea unless you're really invested in a VIM workflow. Source: over 3 years ago

• Vim or Emacs?

  I am a bit confused. What has this anything to do with your original question? vim-pathogen is for Vim editor itself, not for PyCharm. I don't know much about MacOS, so not sure how to help. Did you try the installation steps at... Source: almost 4 years ago

• Usage of 'after/ftplugin' directory for filetype-specific configuration

  Back in the old(ish) days of Vim, usage of tpope/vim-pathogen to manipulate runtimepath was a popular way to install plugins. As it got update 9 days ago, it might be still used by some. Source: about 4 years ago

View more

Tracking GiveForms since Mar 2021.